The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1089
ISSUE1089
October 2, 2000
Eflornithine Cream For Facial Hair Reduction
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Eflornithine Cream For Facial Hair Reduction
October 2, 2000 (Issue: 1089)
Eflornithine hydrochloride cream 13.9% (Vaniqa - Bristol-Myers Squibb) has been approved by the FDA for reduction of unwanted facial hair in women.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.